Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons learned from the DIG trial.

Debra Egan1, Nancy Geller, Salim Yusuf

  • 1National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA. d.a.egan@att.net

Controlled Clinical Trials
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Heart (British Cardiac Society)·2026
Same author

Pharmacokinetics, Safety, and Tolerability of Anti-miR-17 Oligonucleotide RGLS4326 in Healthy Adult Subjects.

Journal of clinical pharmacology·2026
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Nature cancer·2026
Same author

CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Blood advances·2025
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

The Digitalis Investigation Group (DIG) trial demonstrated the success of large simple clinical trials. Key lessons emphasize simplicity, planning, and site support for effective large-scale research.

Area of Science:

  • Clinical Trials Methodology
  • Cardiovascular Research
  • Public Health Initiatives

Background:

  • The Digitalis Investigation Group (DIG) trial was a pioneering large simple clinical trial.
  • This trial was a collaborative effort between the National Heart, Lung, and Blood Institute and the Department of Veterans Affairs.
  • Large simple trials require meticulous planning and operational discipline.

Purpose of the Study:

  • To outline the critical lessons learned from conducting the DIG trial.
  • To provide a framework for future large simple trials.
  • To identify best practices for managing complex, multi-site research.

Main Methods:

  • The DIG trial emphasized simplification in all study procedures and participant engagement.
  • Ancillary studies were incorporated with careful advanced planning.

Related Experiment Videos

  • International drug shipment logistics and regional coordinating centers were managed.
  • Support was provided to research-inexperienced sites for regulatory approvals.
  • Site performance monitoring and investigator enthusiasm were actively maintained.

    • Main Results:

    • Simplification of trial design and procedures is paramount for success.
    • Effective management of ancillary studies, international logistics, and site support is crucial.
    • Continuous monitoring and maintaining investigator engagement are vital for trial progression.
    • Choosing easily ascertainable endpoints and planning for trial closeout are essential.

    Conclusions:

    • The DIG trial provides invaluable insights into the successful execution of large simple trials.
    • Adherence to simplicity, strategic planning, and robust site management are key takeaways.
    • These lessons are transferable to future large-scale clinical research endeavors.